Skip to main content

Day: August 25, 2025

Cemtrex Signs Letters of Intent for Two Strategic Acquisitions in Robotics and Aerospace

New Acquisitions Expected to Drive Total Annual Revenues to $100M and Expand Operating Profit Hauppauge, NY, Aug. 25, 2025 (GLOBE NEWSWIRE) — Cemtrex Inc. (Nasdaq: CETX), a diversified industrial and technology company, today announced it has signed non-binding letters of intent to acquire two profitable U.S.-based businesses — one in industrial robotics integration and the other in aerospace and defense systems engineering. Combined, the two companies are expected to contribute $15–18 million in annual revenue and $2.5–3 million in operating income on a go forward basis, once closed and integrated. “These potential acquisitions directly align with our long-term strategy to expand into high-value markets with strong macro tailwinds,” said Saagar Govil, Chairman and CEO. “We believe both businesses bring meaningful scale, margin,...

Continue reading

Troilus to Accompany Prime Minister of Canada and Minister of Energy and Natural Resources on Critical Minerals Mission to Germany; Also Participating in Japan and Korea Investment Forums

MONTREAL, Aug. 25, 2025 (GLOBE NEWSWIRE) — Troilus Gold Corp. (“Troilus” or the “Company”) (TSX: TLG; OTCQX: CHXMF; FSE: CM5R) is pleased to announce that it has been invited to participate in two upcoming Canadian government-led international missions, underscoring the strategic importance of the Troilus copper-gold project to Canada’s global critical minerals agenda. Troilus has been invited to join the Canadian business delegation accompanying The Right Honourable Mark Carney, Prime Minister of Canada, and The Honourable Tim Hodgson, Minister of Energy and Natural Resources, to Berlin, Germany on August 26 and 27, 2025. This high-level political mission will highlight Canada-Germany cooperation on critical minerals and clean energy and provide Troilus with a platform to showcase its role as one of Québec’s largest future copper-gold...

Continue reading

Twin Hospitality Group Inc. Appoints Andrew Wiederhorn as Chairman of the Board

LOS ANGELES, Aug. 25, 2025 (GLOBE NEWSWIRE) — Twin Hospitality Group Inc. (“Twin Hospitality”) (Nasdaq: TWNP), the parent company of Twin Peaks and Smokey Bones, today announces the appointment of Andrew (Andy) Wiederhorn as Chairman of the Board of Directors, effective immediately. FAT Brands Inc. (NASDAQ: FAT) served as the parent company that executed the strategic spin-out of Twin Hospitality Group earlier this year, separating its Twin Peaks and Smokey Bones restaurant brands into Twin Hospitality Group Inc. Mr. Wiederhorn, the founder of FAT Brands and Chairman of the Board since 2023, played an integral role in the spin-out transaction. “I am honored to serve as Chairman of Twin Hospitality Group during such an exciting time in the Company’s journey,” said Andy Wiederhorn, Chairman of Twin Hospitality Group. “The leadership...

Continue reading

Kinetic Seas and Sagtec Enter into Major Five-Year Agreement to Launch Private White-Labeled SKILLIKS Platform

SCHAUMBURG, Ill. and KUALA LUMPUR, Malaysia, Aug. 25, 2025 (GLOBE NEWSWIRE) — Kinetic Seas Incorporated (OTCQB: KSEZ) and Sagteс Global Limited (NASDAQ: SAGT) today announced the signing of a multi-year agreement to deploy a private white-labeled version of the SKILLIKS AI platform, hosted in the United States. SKILLIKS is the first AI development platform that integrates AI assisted software engineering into enterprise level application and product development. SKILLIKS makes it possible for medium and large organizations to seamlessly integrate AI into their existing software development and support processes. The deal represents a significant investment and underscores the growing importance of AI enablement in Southeast Asia. Through this collaboration, Sagtec will harness the power of the SKILLIKS platform for its internal...

Continue reading

Sagtec Global Secures AI Licensing Deal with Kinetic Seas to Accelerate Scalable Growth in F&B Tech Market

KUALA LUMPUR, MALAYSIA, Aug. 25, 2025 (GLOBE NEWSWIRE) — Sagtec Global (NASDAQ: SAGT), a leading innovator in Point-of-Sale (POS) systems, today announced a strategic licensing agreement with Kinetic Seas Incorporated (OTCQB: KSEZ). Through the agreement, Sagtec will integrate Kinetic Seas’ AI platform, Skilliks, into its portfolio, creating a powerful foundation to scale AI-powered solutions across Southeast Asia’s rapidly growing Food & Beverage (F&B) market. Sagtec currently serves more than 13,000 clients worldwide, many of whom are demanding advanced tools to improve efficiency and profitability. Its flagship POS system, Speed+, already captures high-quality sales data; with AI integration, operators will be able to address critical pain points such as ingredient management and demand forecasting. By licensing Skilliks...

Continue reading

WISeKey Unveils Its Next-Generation WISeID: A Fully Decentralized Identity Platform for People and Objects

WISeKey Unveils Its Next-Generation WISeID: A Fully Decentralized Identity Platform for People and Objects Geneva, Switzerland – August 25, 2025 – WISeKey International Holding Ltd. (“WISeKey”) (SIX: WIHN, NASDAQ: WKEY), a global leader in cybersecurity, blockchain, and IoT, today announced the convergence of WISeID, its people identity platform, and SEALCOIN, its object identity platform, into a unified decentralized identity framework designed for the decentralized internet. This next-generation WISeID builds upon WISeKey’s 25-year leadership in digital identity to create a Self-Sovereign Identity (SSI) platform where individuals and connected devices can securely interact, transact, and authenticate with full autonomy. WISeID was among the first digital identity technologies on the Internet, launched in 1999 together with WISeKey’s...

Continue reading

Nobel Sustainability Trust Chairman Peter Nobel and MFH CSO Wilfred Daye Join Mercurity Fintech Board

Appointment of prestigious Nobel family leader is a major stepping stone in the convergence of traditional finance and next-gen innovation New York, NY, Aug. 25, 2025 (GLOBE NEWSWIRE) — Mercurity Fintech Holding Inc. (the “Company,” “we,” “us,” “our company,” or “MFH”) (Nasdaq: MFH), a blockchain-powered fintech group and Russell 2000 Index member, today announced the appointment of Peter Nobel as Independent Director and Wilfred Daye, Chief Strategy Officer (CSO) of MFH, as Director to its Board of Directors. Nobel, Chairman of the Nobel Sustainability Trust Foundation and a core figure of the Nobel family legacy, brings decades of leadership in global sustainability, industrial innovation, and ethical governance. He previously held senior executive roles at leading firms such as Alfa Laval and SWEP International, where he spearheaded...

Continue reading

POET Technologies to Proceed with Voluntary Delisting from TSXV

No change to Nasdaq listing; common shares continue to be listed under symbol “POET” TORONTO, Aug. 25, 2025 (GLOBE NEWSWIRE) — POET Technologies Inc. (“POET” or the “Company“) (TSX Venture: PTK; NASDAQ: POET), the designer and developer of the POET Optical Interposer™, Photonic Integrated Circuits (PICs) and light sources for the data center, tele-communication and artificial intelligence markets, today announced that it will shortly be proceeding with the previously-announced voluntary delisting of its common shares (the “Shares“) from the TSX Venture Exchange (“TSXV“). The delisting from the TSXV will not affect the Company’s listing on Nasdaq Capital Market (the “Nasdaq“) and POET’s Shares will continue to be listed on Nasdaq under the...

Continue reading

PDS Biotech Announces Final Topline Survival Data from VERSATILE-002 Phase 2 Trial in Head and Neck Cancer

Median Overall Survival (mOS) of 39.3 months in patients with CPS ≥ 1 – best published result with standard of care pembrolizumab or pembrolizumab + chemotherapy is 17.9 months* VERSATILE-003 Phase 3 trial in progress PRINCETON, N.J., Aug. 25, 2025 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today announced final topline survival data from its VERSATILE-002 Phase 2 clinical trial. VERSATILE-002 evaluated PDS0101 (Versamune® HPV) + Keytruda® (pembrolizumab) in patients with HPV16-positive first-line recurrent and/or metastatic head and neck squamous cell cancer (“1L R/M HNSCC”).53 patients were enrolled in the 1L R/M HNSCC arm of the trial. PDS0101 was administered by...

Continue reading

NewtekOne, Inc. Closes Offering of Depositary Shares Each Representing 1/40th of an Interest in its Series 8.500% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock, Series B

BOCA RATON, Fla., Aug. 25, 2025 (GLOBE NEWSWIRE) — On August 20, 2025, NewtekOne, Inc. (the “Company” or “NewtekOne”) (NASDAQ: NEWT) successfully closed an offering of 2,000,000 depositary shares (the “Depositary Shares”), each representing a 1/40th interest in a share of the Company’s 8.500% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock, Series B (the “Series B Preferred Stock”), with a liquidation preference of $1,000 per share (equivalent to $25.00 per Depositary Share). The offering generated approximately $48.357 million in net proceeds to the Company. In addition, the Company granted the underwriters a 30-day option to purchase up to an additional 150,000 Depositary Shares at the public offering price less the applicable underwriting discount. The newly issued Series B Preferred Stock will pay (and the holders...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.